Concepts (203)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Magnetic Resonance Spectroscopy | 32 | 2023 | 289 | 3.950 |
Why?
|
| Brain | 22 | 2023 | 1346 | 2.400 |
Why?
|
| Neuroglia | 3 | 2016 | 124 | 1.190 |
Why?
|
| Glutamic Acid | 7 | 2009 | 128 | 1.120 |
Why?
|
| HIV Infections | 13 | 2023 | 2303 | 1.090 |
Why?
|
| Brain Chemistry | 6 | 2013 | 140 | 1.000 |
Why?
|
| Magnetic Resonance Imaging | 15 | 2023 | 481 | 0.990 |
Why?
|
| gamma-Aminobutyric Acid | 7 | 2023 | 79 | 0.850 |
Why?
|
| Anti-HIV Agents | 3 | 2016 | 420 | 0.810 |
Why?
|
| Frontal Lobe | 3 | 2010 | 48 | 0.750 |
Why?
|
| Bicarbonates | 3 | 2013 | 13 | 0.640 |
Why?
|
| Antiretroviral Therapy, Highly Active | 2 | 2016 | 221 | 0.590 |
Why?
|
| DNA, Viral | 3 | 2013 | 304 | 0.580 |
Why?
|
| Carbon Isotopes | 5 | 2013 | 38 | 0.580 |
Why?
|
| Glutathione | 4 | 2018 | 179 | 0.570 |
Why?
|
| Adult | 33 | 2023 | 11712 | 0.530 |
Why?
|
| Acetates | 2 | 2010 | 21 | 0.460 |
Why?
|
| Acid-Base Equilibrium | 1 | 2013 | 7 | 0.460 |
Why?
|
| Male | 40 | 2023 | 20025 | 0.450 |
Why?
|
| Psychotic Disorders | 3 | 2019 | 55 | 0.450 |
Why?
|
| Fasting | 1 | 2013 | 54 | 0.440 |
Why?
|
| Neurons | 3 | 2016 | 1175 | 0.440 |
Why?
|
| Contrast Media | 2 | 2012 | 92 | 0.440 |
Why?
|
| Cerebellum | 1 | 2013 | 73 | 0.440 |
Why?
|
| Cerebral Cortex | 2 | 2013 | 290 | 0.420 |
Why?
|
| Humans | 51 | 2023 | 37093 | 0.410 |
Why?
|
| HIV Seropositivity | 2 | 2013 | 190 | 0.390 |
Why?
|
| Female | 29 | 2020 | 20969 | 0.370 |
Why?
|
| Schizophrenia | 2 | 2022 | 76 | 0.350 |
Why?
|
| Drug Discovery | 1 | 2011 | 82 | 0.350 |
Why?
|
| Drug Users | 1 | 2009 | 46 | 0.340 |
Why?
|
| Amphetamine-Related Disorders | 1 | 2009 | 65 | 0.340 |
Why?
|
| Aspartic Acid | 6 | 2016 | 47 | 0.330 |
Why?
|
| Receptors, GABA | 2 | 2019 | 25 | 0.320 |
Why?
|
| Anti-Retroviral Agents | 3 | 2021 | 147 | 0.320 |
Why?
|
| Methamphetamine | 1 | 2009 | 159 | 0.300 |
Why?
|
| Young Adult | 14 | 2023 | 4268 | 0.300 |
Why?
|
| Prefrontal Cortex | 2 | 2019 | 137 | 0.290 |
Why?
|
| Central Nervous System | 3 | 2021 | 135 | 0.280 |
Why?
|
| Middle Aged | 15 | 2023 | 10129 | 0.280 |
Why?
|
| Image Processing, Computer-Assisted | 5 | 2010 | 173 | 0.250 |
Why?
|
| Mental Disorders | 1 | 2008 | 309 | 0.250 |
Why?
|
| Myoglobin | 8 | 2008 | 17 | 0.240 |
Why?
|
| Muscle, Skeletal | 6 | 2004 | 282 | 0.230 |
Why?
|
| Water | 4 | 2019 | 296 | 0.230 |
Why?
|
| Image Enhancement | 4 | 2012 | 40 | 0.220 |
Why?
|
| Clozapine | 1 | 2022 | 17 | 0.220 |
Why?
|
| Cognition Disorders | 2 | 2016 | 233 | 0.210 |
Why?
|
| Reference Values | 5 | 2019 | 212 | 0.210 |
Why?
|
| Positron-Emission Tomography | 2 | 2019 | 80 | 0.200 |
Why?
|
| Choline | 5 | 2016 | 59 | 0.190 |
Why?
|
| Signal Processing, Computer-Assisted | 3 | 2006 | 61 | 0.190 |
Why?
|
| Oxygen Consumption | 4 | 2010 | 103 | 0.180 |
Why?
|
| Oxygen | 7 | 2008 | 207 | 0.170 |
Why?
|
| Brain Neoplasms | 2 | 2017 | 111 | 0.170 |
Why?
|
| Tissue Distribution | 3 | 2017 | 207 | 0.170 |
Why?
|
| Commerce | 1 | 2020 | 87 | 0.170 |
Why?
|
| Pilot Projects | 2 | 2013 | 661 | 0.170 |
Why?
|
| Reproducibility of Results | 6 | 2023 | 935 | 0.170 |
Why?
|
| Creatine | 5 | 2010 | 8 | 0.170 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2018 | 21 | 0.160 |
Why?
|
| Heroin | 1 | 2018 | 13 | 0.160 |
Why?
|
| RNA, Viral | 2 | 2017 | 301 | 0.160 |
Why?
|
| Neurotransmitter Agents | 1 | 1998 | 63 | 0.160 |
Why?
|
| Antigens, CD | 1 | 2018 | 121 | 0.160 |
Why?
|
| Receptors, Cell Surface | 1 | 2018 | 144 | 0.150 |
Why?
|
| Glutathione Peroxidase | 1 | 2018 | 111 | 0.150 |
Why?
|
| Isocitrate Dehydrogenase | 1 | 2017 | 8 | 0.150 |
Why?
|
| Acute Disease | 3 | 2012 | 147 | 0.150 |
Why?
|
| Molecular Imaging | 1 | 2017 | 30 | 0.140 |
Why?
|
| Lymphocyte Activation | 1 | 2017 | 236 | 0.140 |
Why?
|
| Brain Injuries | 1 | 2018 | 121 | 0.140 |
Why?
|
| Antioxidants | 2 | 2018 | 416 | 0.140 |
Why?
|
| Seals, Earless | 2 | 2008 | 6 | 0.130 |
Why?
|
| HIV Integrase Inhibitors | 1 | 2015 | 7 | 0.130 |
Why?
|
| Receptors, CCR5 | 1 | 2015 | 61 | 0.130 |
Why?
|
| Cocaine | 1 | 2018 | 232 | 0.130 |
Why?
|
| Neurofilament Proteins | 1 | 2015 | 29 | 0.130 |
Why?
|
| HIV | 3 | 2023 | 98 | 0.130 |
Why?
|
| Phantoms, Imaging | 6 | 2010 | 24 | 0.120 |
Why?
|
| Sensitivity and Specificity | 4 | 2012 | 562 | 0.120 |
Why?
|
| Cross-Sectional Studies | 3 | 2023 | 2721 | 0.120 |
Why?
|
| Oxidation-Reduction | 2 | 2018 | 431 | 0.120 |
Why?
|
| Phosphorus Isotopes | 1 | 2013 | 8 | 0.110 |
Why?
|
| Risk | 3 | 2019 | 267 | 0.110 |
Why?
|
| Spectrum Analysis | 2 | 2011 | 54 | 0.110 |
Why?
|
| Atrophy | 1 | 2013 | 42 | 0.110 |
Why?
|
| Quality Control | 1 | 2012 | 36 | 0.110 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2012 | 11 | 0.110 |
Why?
|
| Inositol | 4 | 2005 | 21 | 0.110 |
Why?
|
| Phosphocreatine | 2 | 2010 | 11 | 0.110 |
Why?
|
| Central Nervous System Infections | 1 | 2012 | 4 | 0.110 |
Why?
|
| Succinates | 1 | 2011 | 3 | 0.100 |
Why?
|
| Protons | 3 | 2004 | 84 | 0.100 |
Why?
|
| Arteries | 1 | 2012 | 65 | 0.100 |
Why?
|
| Citric Acid Cycle | 1 | 2011 | 6 | 0.100 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2013 | 364 | 0.100 |
Why?
|
| Glucose | 2 | 2010 | 230 | 0.100 |
Why?
|
| Adolescent | 6 | 2023 | 5363 | 0.100 |
Why?
|
| Case-Control Studies | 3 | 2009 | 1130 | 0.100 |
Why?
|
| Depression | 1 | 2017 | 712 | 0.100 |
Why?
|
| Aging | 1 | 2016 | 664 | 0.100 |
Why?
|
| Carbon Radioisotopes | 1 | 2010 | 11 | 0.090 |
Why?
|
| Chemistry, Pharmaceutical | 1 | 2011 | 71 | 0.090 |
Why?
|
| Exercise | 4 | 2000 | 613 | 0.090 |
Why?
|
| Anxiety | 1 | 2017 | 754 | 0.090 |
Why?
|
| Kinetics | 2 | 2010 | 708 | 0.090 |
Why?
|
| Metabolomics | 1 | 2011 | 81 | 0.090 |
Why?
|
| Animals | 7 | 2012 | 15081 | 0.090 |
Why?
|
| Prospective Studies | 3 | 2020 | 1378 | 0.090 |
Why?
|
| Ornithine Carbamoyltransferase Deficiency Disease | 1 | 2009 | 2 | 0.090 |
Why?
|
| Thailand | 2 | 2020 | 48 | 0.080 |
Why?
|
| Cell Respiration | 2 | 2008 | 35 | 0.080 |
Why?
|
| Anilides | 2 | 2019 | 28 | 0.080 |
Why?
|
| Analysis of Variance | 2 | 2007 | 550 | 0.080 |
Why?
|
| Treatment Outcome | 1 | 2012 | 1369 | 0.080 |
Why?
|
| Muscles | 1 | 2008 | 82 | 0.080 |
Why?
|
| Sleep Apnea Syndromes | 1 | 2008 | 29 | 0.080 |
Why?
|
| Viral Load | 2 | 2021 | 312 | 0.080 |
Why?
|
| Nervous System Diseases | 1 | 2008 | 71 | 0.080 |
Why?
|
| Pyridines | 2 | 2019 | 116 | 0.080 |
Why?
|
| Autopsy | 2 | 2018 | 43 | 0.070 |
Why?
|
| Inflammation | 1 | 2012 | 618 | 0.070 |
Why?
|
| Decision Making | 1 | 2008 | 203 | 0.070 |
Why?
|
| Spectroscopy, Near-Infrared | 3 | 2000 | 30 | 0.060 |
Why?
|
| Multiple Sclerosis | 1 | 2005 | 45 | 0.060 |
Why?
|
| Lactates | 1 | 2004 | 8 | 0.060 |
Why?
|
| Muscle Contraction | 1 | 2004 | 66 | 0.060 |
Why?
|
| Aged | 4 | 2016 | 6741 | 0.060 |
Why?
|
| Age Factors | 1 | 2007 | 1033 | 0.060 |
Why?
|
| Sex Factors | 1 | 2007 | 898 | 0.060 |
Why?
|
| Energy Metabolism | 1 | 2004 | 168 | 0.060 |
Why?
|
| Glutamine | 2 | 2004 | 40 | 0.050 |
Why?
|
| Apnea | 1 | 2002 | 6 | 0.050 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2021 | 18 | 0.050 |
Why?
|
| Citrates | 1 | 2001 | 14 | 0.050 |
Why?
|
| Prostatic Neoplasms | 2 | 2001 | 935 | 0.050 |
Why?
|
| Polyamines | 1 | 2001 | 30 | 0.050 |
Why?
|
| Oxidative Stress | 2 | 2018 | 938 | 0.050 |
Why?
|
| Prostate | 1 | 2001 | 154 | 0.040 |
Why?
|
| Organ Size | 1 | 2020 | 157 | 0.040 |
Why?
|
| ROC Curve | 2 | 2013 | 138 | 0.040 |
Why?
|
| Intracellular Membranes | 1 | 1999 | 38 | 0.040 |
Why?
|
| Heroin Dependence | 1 | 2018 | 23 | 0.040 |
Why?
|
| Rats, Wistar | 2 | 2012 | 233 | 0.040 |
Why?
|
| Radiopharmaceuticals | 1 | 2018 | 55 | 0.040 |
Why?
|
| Cocaine-Related Disorders | 1 | 2018 | 85 | 0.040 |
Why?
|
| Alzheimer Disease | 1 | 2005 | 905 | 0.040 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2017 | 189 | 0.040 |
Why?
|
| Algorithms | 3 | 2010 | 465 | 0.040 |
Why?
|
| Evidence-Based Medicine | 1 | 2017 | 97 | 0.040 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 3 | 2004 | 84 | 0.040 |
Why?
|
| Aged, 80 and over | 2 | 2016 | 2379 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2015 | 227 | 0.030 |
Why?
|
| Dipeptides | 2 | 2004 | 32 | 0.030 |
Why?
|
| Infant, Newborn | 1 | 2016 | 894 | 0.030 |
Why?
|
| Adenosine Diphosphate | 2 | 2004 | 21 | 0.030 |
Why?
|
| Blood Flow Velocity | 1 | 2012 | 61 | 0.030 |
Why?
|
| Static Electricity | 1 | 2012 | 78 | 0.030 |
Why?
|
| Infant | 1 | 2016 | 1046 | 0.030 |
Why?
|
| Regression Analysis | 1 | 2013 | 455 | 0.030 |
Why?
|
| Host-Pathogen Interactions | 1 | 2013 | 186 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2012 | 208 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2013 | 583 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2016 | 1418 | 0.020 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2011 | 61 | 0.020 |
Why?
|
| Rats | 2 | 2012 | 3483 | 0.020 |
Why?
|
| Monocytes | 1 | 2013 | 257 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2015 | 1492 | 0.020 |
Why?
|
| Electromagnetic Fields | 1 | 2010 | 8 | 0.020 |
Why?
|
| Microwaves | 1 | 2010 | 24 | 0.020 |
Why?
|
| Free Radicals | 1 | 2010 | 74 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2011 | 661 | 0.020 |
Why?
|
| Cytokines | 1 | 2013 | 602 | 0.020 |
Why?
|
| Partial Pressure | 2 | 1999 | 9 | 0.020 |
Why?
|
| Polyphosphates | 1 | 2008 | 3 | 0.020 |
Why?
|
| Neurochemistry | 1 | 2008 | 6 | 0.020 |
Why?
|
| Hemodynamics | 1 | 2008 | 91 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2010 | 421 | 0.020 |
Why?
|
| Child | 1 | 2016 | 3131 | 0.020 |
Why?
|
| Temperature | 1 | 2008 | 286 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2011 | 2026 | 0.020 |
Why?
|
| Discriminant Analysis | 1 | 2005 | 23 | 0.020 |
Why?
|
| Risk Factors | 1 | 2013 | 3562 | 0.020 |
Why?
|
| Phosphates | 1 | 2004 | 51 | 0.020 |
Why?
|
| Radio Waves | 1 | 2004 | 4 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2005 | 217 | 0.020 |
Why?
|
| Anesthesia | 1 | 2004 | 14 | 0.020 |
Why?
|
| Body Water | 1 | 2004 | 26 | 0.010 |
Why?
|
| Fourier Analysis | 1 | 2004 | 43 | 0.010 |
Why?
|
| Hydrogen | 1 | 2004 | 47 | 0.010 |
Why?
|
| Adenosine Triphosphate | 1 | 2004 | 196 | 0.010 |
Why?
|
| Neuropeptides | 1 | 2004 | 59 | 0.010 |
Why?
|
| Diving | 1 | 2002 | 2 | 0.010 |
Why?
|
| Oxyhemoglobins | 1 | 2002 | 5 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2005 | 484 | 0.010 |
Why?
|
| Mice | 1 | 2011 | 5913 | 0.010 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2001 | 172 | 0.010 |
Why?
|
| Oxidative Phosphorylation | 1 | 2000 | 53 | 0.010 |
Why?
|
| Constriction | 1 | 1999 | 3 | 0.010 |
Why?
|
| Leg | 1 | 1999 | 19 | 0.010 |
Why?
|
| Hemoglobins | 1 | 1999 | 107 | 0.010 |
Why?
|
| Prognosis | 1 | 2001 | 739 | 0.010 |
Why?
|